$179 Million is the total value of Prosight Management, LP's 32 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 74.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HNGR | New | HANGER INC | $24,988,000 | – | 1,199,602 | +100.0% | 13.93% | – |
| TLGT | Sell | TELIGENT INC NEW | $12,801,000 | +11.3% | 3,240,761 | -2.5% | 7.14% | -15.4% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $11,231,000 | +84.6% | 244,050 | +74.9% | 6.26% | +40.4% |
| MGNX | Sell | MACROGENICS INC | $9,808,000 | -23.2% | 457,475 | -26.0% | 5.47% | -41.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $9,351,000 | +71.5% | 96,428 | +66.5% | 5.21% | +30.4% |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $9,307,000 | +35.0% | 1,661,940 | +22.2% | 5.19% | +2.7% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $8,405,000 | – | 63,930 | +100.0% | 4.69% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $8,047,000 | +42.9% | 715,317 | +62.6% | 4.49% | +8.7% |
| Buy | INTEC PHARMA LTD JERUSALEM | $7,555,000 | +52.6% | 1,337,191 | +18.8% | 4.21% | +16.1% | |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $6,553,000 | +125.5% | 80,155 | -3.5% | 3.65% | +71.5% |
| CI | Sell | CIGNA CORPORATION | $6,088,000 | -53.7% | 29,236 | -62.2% | 3.40% | -64.8% |
| AGN | Sell | ALLERGAN PLC | $5,981,000 | -50.0% | 31,400 | -56.2% | 3.34% | -61.9% |
| PRSC | New | PROVIDENCE SVC CORP | $5,733,000 | – | 85,217 | +100.0% | 3.20% | – |
| ALBO | New | ALBIREO PHARMA INC | $5,369,000 | – | 162,905 | +100.0% | 2.99% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $4,780,000 | – | 274,410 | +100.0% | 2.66% | – |
| SRRA | Buy | SIERRA ONCOLOGY INC | $4,624,000 | -13.5% | 2,720,089 | +50.6% | 2.58% | -34.2% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $4,441,000 | +73.5% | 119,578 | +83.1% | 2.48% | +31.9% |
| KURA | Sell | KURA ONCOLOGY INC | $4,439,000 | -15.3% | 253,631 | -11.9% | 2.48% | -35.6% |
| SHPG | Sell | SHIRE PLCsponsored adr | $4,242,000 | -21.5% | 23,400 | -26.9% | 2.36% | -40.3% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $4,097,000 | -23.4% | 341,457 | -22.1% | 2.28% | -41.7% |
| New | RETROPHIN INCput | $2,939,000 | – | 102,300 | +100.0% | 1.64% | – | |
| CNC | Buy | CENTENE CORP DEL | $2,878,000 | +114.8% | 19,875 | +82.8% | 1.60% | +63.4% |
| AXGN | New | AXOGEN INC | $2,828,000 | – | 76,741 | +100.0% | 1.58% | – |
| EOLS | New | EVOLUS INC | $2,578,000 | – | 138,460 | +100.0% | 1.44% | – |
| CBIO | New | CATALYST BIOSCIENCES INC | $2,550,000 | – | 236,558 | +100.0% | 1.42% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $2,056,000 | – | 423,846 | +100.0% | 1.15% | – |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $1,430,000 | -76.3% | 324,902 | -72.0% | 0.80% | -82.0% |
| NVLNF | Buy | NOVELION THERAPEUTICS INC | $1,314,000 | +83.5% | 444,068 | +128.1% | 0.73% | +39.6% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $1,120,000 | +55.3% | 52,331 | +25.5% | 0.62% | +18.1% |
| OVAS | New | OVASCIENCE INC | $1,116,000 | – | 1,529,700 | +100.0% | 0.62% | – |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $527,000 | – | 38,746 | +100.0% | 0.29% | – |
| AQXP | Sell | AQUINOX PHARMACEUTICALS INC | $166,000 | -84.4% | 56,650 | -85.9% | 0.09% | -88.1% |
| Exit | AVEO PHARMACEUTICALS INCcall | $0 | – | -70,100 | -100.0% | -0.12% | – | |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -149,073 | -100.0% | -0.25% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -19,388 | -100.0% | -0.40% | – |
| CIVI | Exit | CIVITAS SOLUTIONS INC | $0 | – | -34,649 | -100.0% | -0.42% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -421,414 | -100.0% | -1.08% | – | |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -144,752 | -100.0% | -1.08% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -48,800 | -100.0% | -1.40% | – |
| SBRA | Exit | SABRA HEALTH CARE REIT INC | $0 | – | -98,906 | -100.0% | -1.58% | – |
| MYL | Exit | MYLAN N V | $0 | – | -80,800 | -100.0% | -2.14% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -375,000 | -100.0% | -2.38% | – |
| ATHN | Exit | ATHENAHEALTH INC | $0 | – | -41,193 | -100.0% | -4.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-09-01 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.